Anixa Biosciences (ANIX) Financial Ratios

For fiscal 2025 (fiscal year ended Oct 31, 2025), Anixa Biosciences had return on equity of -67.2% (down from -60.1%), debt-to-equity of 0.01 (up from 0.01), a current ratio of 8.08 (down from 8.54) and return on assets of -38.8% (down from -36.7%). A current ratio of 8.08 means current assets exceed current liabilities.

Anixa Biosciences Financial Ratios Analysis

Valuation, profitability, leverage, and liquidity ratios

Income Statement Balance Sheet Cash Flow Ratios

Scroll to see more

Breakdown	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period ending	Oct 2025	Oct 2024	Oct 2023	Oct 2022	Oct 2021	Oct 2020
Valuation Ratios
Forward P/E	4.85	4.85	4.85	4.27	4.27	-
P/S Ratio	-	-	467.53	-	279.02	-
P/B Ratio	9.74	5.96	4.20	6.09	4.11	5.93
Price/Tangible Book	8.97	5.63	4.03	5.91	4.03	5.59
Enterprise Value Ratios
EV/Revenue	-	-	342.38	-	206.32	-
Profitability & Returns
Return on Equity (ROE)	-67.17%	-60.10%	-38.51%	-43.74%	-61.02%	-154.36%
Return on Assets (ROA)	-38.83%	-36.70%	-24.61%	-26.01%	-35.92%	-81.88%
Return on Invested Capital (ROIC)	-	-	-	-	-	-98.19%
Return on Capital Employed (ROCE)	-82.90%	-72.40%	-46.90%	-48.90%	-37.50%	-124.80%
Leverage & Solvency Ratios
Debt/Equity	0.01	0.01	0.01	0.01	0.01	0.01
Liquidity Ratios
Current Ratio	8.08	8.54	12.50	14.83	28.35	7.88
Quick Ratio	7.71	8.04	11.89	14.60	28.13	7.62
Efficiency Ratios
Asset Turnover	-	-	0.01	-	0.02	-
Yield & Distribution Ratios
Earnings Yield	-8.04%	-11.15%	-9.99%	-7.92%	-9.07%	-20.44%
FCF Yield	-5.28%	-6.51%	-6.32%	-3.78%	-3.46%	-12.63%
Buyback Yield	-1.74%	-2.96%	-1.99%	-6.28%	-28.57%	-12.33%

Source: Company financial statements from annual and quarterly filings. Data as of Jul 31, 2026. Data sources and methodology

Frequently Asked Questions About Anixa Biosciences Financial Ratios

What is Anixa Biosciences's return on equity?

Anixa Biosciences's return on equity (ROE) was -67.2% for fiscal 2025 (period ended Oct 31, 2025). It was -60.1% a year earlier.

What is Anixa Biosciences's debt-to-equity ratio?

Anixa Biosciences's debt-to-equity ratio was 0.01 for fiscal 2025 (period ended Oct 31, 2025). It was 0.01 a year earlier.

What is return on equity (ROE)?

Return on equity is net income divided by shareholders' equity. It measures how much profit a company generates from the capital its shareholders have invested. Full definition